Hepatitis C Medicines - Fact Sheet for Public and Private Hospital Prescribers & Dispensers

A range of medicines for the treatment of hepatitis C are available through the Pharmaceutical Benefits Scheme (PBS), through both the PBS General Schedule and the Section 100 Highly Specialised Drugs (HSD) Program.  The Pharmaceutical Benefits Advisory Committee recommended these medicines be made available in this way to ensure the broadest possible access.

Patient eligibility is the same whether the medicines are prescribed through the General Schedule or the S100 HSD program.

Using the right listing at the time of prescribing will help patients to get their prescription filled by the right pharmacy.

For dispensing through the community setting, Hospital Prescribers should:

Use the General Schedule listing to allow dispensing through community pharmacy (NB. General Schedule not to be used for public patients receiving treatment at NSW/ACT public hospitals).

  • Practitioner should prescribe, and seek Medicare ‘authority’, using the General Schedule listing. The authority number will not have a prefix (identifying it as a General Schedule script)
  • Patient should be advised to have the original and any repeat scripts dispensed at a community pharmacy

Benefits:

Patient - can access the medicine at their local pharmacy 

Community Pharmacy – fees & mark-ups reflect the community pharmacy delivery chain

For dispensing through hospital pharmacies, Hospital Prescribers should:

Use the Section 100 Highly Specialised Drugs listing if specific circumstances require dispensing through Public Hospital or Private Hospital Pharmacy:

  • Practitioner should prescribe & seek Medicare ‘authority’ using the S100 Highly Specialised Drugs program – the authority number issued by Medicare will have a PTE or PUB prefix (identifying it as a S100 prescription)
  • Patient should be advised to have the original and any repeat prescriptions dispensed at the hospital pharmacy

Benefits:

Patient – if patient requires access through hospital pharmacy this can be accommodated

Hospital Pharmacy – mark-ups reflect the appropriate amount for the dispensing environment

Pharmacists can differentiate between General Schedule prescriptions and S100 HSD Public and Private prescriptions by the inclusion or lack of a HSD prefix on the Medicare (DHS) authority approval code:

Phone Written
General schedule (S85) Z1234AB* Round, red stamp that says:
Approved by PBS-DHS
S100 Private PTE Z1234AB* Round, red stamps that say:
Approved by PBS-DHS and PRIVATE HOSPITAL (item code)
S100 Public PUB Z1234AB* Round, red stamps that say:
Approved by PBS-DHS and PUBLIC HOSPITAL (item code)

*These are sample codes only. The actual authority number may be different.

The following tables provide the appropriate item codes for the high cost Hepatitis medicines under each PBS program.

General Schedule

The following item codes will be used for General Schedule authority approvals against the listed medicines depending on the numbers of repeats:

  Harvoni Sovaldi Daklinza 30mg Daklinza 60mg Viekira Pak Viekira Pak-RBV 200mg Viekira Pak-RBV 600mg Zepatier
8 weeks (1 original + 1 repeat) 10668L - - - - - - -
12 weeks (1 original + 2 repeats) 10628J 10624E 10645G 10642D 10766P 10772Y 10769T 11021C
16 weeks (1 original + 3 repeats) - - - - - - - 11011M
24 weeks (1 original + 5 repeats) 10670N 10657X 10671P 10659B - 10771X 10747P -

S100 HSD Private

The following item codes will be used for S100 HSD Private Hospital authority approvals against the listed medicines depending on the numbers of repeats:

  Harvoni Sovaldi Daklinza 30mg Daklinza 60mg Viekira Pak Viekira Pak-RBV 200mg Viekira Pak-RBV 600mg Zepatier
8 weeks (1 original + 1 repeat) 10653Q - - - - - - -
12 weeks (1 original + 2 repeats) 10672Q 10654R 10643E 10644F 10749R 10753Y 10750T 10979W
16 weeks (1 original + 3 repeats) - - - - - - - 10991L
24 weeks (1 original + 5 repeats) 10679C 10676X 10630L 10631M - 10761J 10773B -

S100 HSD Public

The following item codes will be used for S100 HSD Public hospital authority approvals against the listed medicines depending on the numbers of repeats:

Harvoni Sovaldi Daklinza 30mg Daklinza 60mg Viekira Pak Viekira Pak-RBV 200mg Viekira Pak-RBV 600mg Zepatier
8 weeks (1 original + 1 repeat) 10667K - - - - - - -
12 weeks (1 original + 2 repeats) 10661D 10625F 10651N 10660C 10751W 10765N 10754B 10978T
16 weeks (1 original + 3 repeats) - - - - - - - 10986F
24 weeks (1 original + 5 repeats) 10669M 10648K 10629K 10641C - 10752X 10768R -

Last updated
1 June 2017